Literature DB >> 16512664

Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines.

Gerald V Denis1, Mark E McComb, Douglas V Faller, Anupama Sinha, Paul B Romesser, Catherine E Costello.   

Abstract

We use affinity purification of the double bromodomain protein Brd2 to isolate a multicomponent nuclear complex from cultured cells, and apply mass spectrometry/proteomics methods to identify the participants. We then confirm by immunoblot several transcription co-activators and co-repressors, proteins of the Swi/Snf chromatin remodeling complex, which regulate transcription control of cyclin A. This multiprotein complex is likely to contribute to cell cycle control and play a role in proliferation and cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16512664      PMCID: PMC2823066          DOI: 10.1021/pr050430u

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  49 in total

1.  Requirement for TAF(II)250 acetyltransferase activity in cell cycle progression.

Authors:  E L Dunphy; T Johnson; S S Auerbach; E H Wang
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

2.  Bromodomain factor 1 (Bdf1) protein interacts with histones.

Authors:  M Pamblanco; A Poveda; R Sendra; S Rodríguez-Navarro; J E Pérez-Ortín; V Tordera
Journal:  FEBS Lett       Date:  2001-05-04       Impact factor: 4.124

Review 3.  Acetylation of histones and transcription-related factors.

Authors:  D E Sterner; S L Berger
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

4.  A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G(2)-to-M transition.

Authors:  A Dey; J Ellenberg; A Farina; A E Coleman; T Maruyama; S Sciortino; J Lippincott-Schwartz; K Ozato
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

5.  Bromodomain factor 1 corresponds to a missing piece of yeast TFIID.

Authors:  O Matangkasombut; R M Buratowski; N W Swilling; S Buratowski
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

Review 6.  You bet-cha: a novel family of transcriptional regulators.

Authors:  B Florence; D V Faller
Journal:  Front Biosci       Date:  2001-08-01

7.  RING3 kinase transactivates promoters of cell cycle regulatory genes through E2F.

Authors:  G V Denis; C Vaziri; N Guo; D V Faller
Journal:  Cell Growth Differ       Date:  2000-08

8.  Insights into the role of histone H3 and histone H4 core modifiable residues in Saccharomyces cerevisiae.

Authors:  Edel M Hyland; Michael S Cosgrove; Henrik Molina; Dongxia Wang; Akhilesh Pandey; Robert J Cottee; Jef D Boeke
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

9.  A novel human Ada2 homologue functions with Gcn5 or Brg1 to coactivate transcription.

Authors:  Nickolai A Barlev; Alexander V Emelyanov; Paola Castagnino; Philip Zegerman; Andrew J Bannister; Manuel A Sepulveda; Flavie Robert; Laszlo Tora; Tony Kouzarides; Barbara K Birshtein; Shelley L Berger
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

10.  Activation-induced nuclear translocation of RING3.

Authors:  N Guo; D V Faller; G V Denis
Journal:  J Cell Sci       Date:  2000-09       Impact factor: 5.285

View more
  77 in total

Review 1.  Basic concepts of epigenetics: impact of environmental signals on gene expression.

Authors:  Elizabeth A Mazzio; Karam F A Soliman
Journal:  Epigenetics       Date:  2012-02       Impact factor: 4.528

Review 2.  Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation.

Authors:  Gerald V Denis
Journal:  Discov Med       Date:  2010-12       Impact factor: 2.970

Review 3.  BET domain co-regulators in obesity, inflammation and cancer.

Authors:  Anna C Belkina; Gerald V Denis
Journal:  Nat Rev Cancer       Date:  2012-06-22       Impact factor: 60.716

4.  Brd2 is a TBP-associated protein and recruits TBP into E2F-1 transcriptional complex in response to serum stimulation.

Authors:  Jinhong Peng; Wei Dong; Lu Chen; Tingting Zou; Yipeng Qi; Yingle Liu
Journal:  Mol Cell Biochem       Date:  2006-11-17       Impact factor: 3.396

5.  Development of a malignancy-associated proteomic signature for diffuse large B-cell lymphoma.

Authors:  Paul B Romesser; David H Perlman; Douglas V Faller; Catherine E Costello; Mark E McComb; Gerald V Denis
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

6.  The interaction of the gammaherpesvirus 68 orf73 protein with cellular BET proteins affects the activation of cell cycle promoters.

Authors:  Matthias Ottinger; Daniel Pliquet; Thomas Christalla; Ronald Frank; James P Stewart; Thomas F Schulz
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

7.  Brd2 disruption in mice causes severe obesity without Type 2 diabetes.

Authors:  Fangnian Wang; Hongsheng Liu; Wanda P Blanton; Anna Belkina; Nathan K Lebrasseur; Gerald V Denis
Journal:  Biochem J       Date:  2009-12-14       Impact factor: 3.857

Review 8.  BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer.

Authors:  Sofia Genta; Maria Cristina Pirosa; Anastasios Stathis
Journal:  Curr Oncol Rep       Date:  2019-02-04       Impact factor: 5.075

9.  Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development.

Authors:  Pan Tang; Jifa Zhang; Jie Liu; Cheng-Ming Chiang; Liang Ouyang
Journal:  J Med Chem       Date:  2021-02-22       Impact factor: 7.446

10.  BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.

Authors:  Daniela Boehm; Vincenzo Calvanese; Roy D Dar; Sifei Xing; Sebastian Schroeder; Laura Martins; Katherine Aull; Pao-Chen Li; Vicente Planelles; James E Bradner; Ming-Ming Zhou; Robert F Siliciano; Leor Weinberger; Eric Verdin; Melanie Ott
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.